Deborah Marsh

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Disorders

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Hahn Michael A; McDonnell Julie; Marsh Deborah J
The effect of disease-associated HRPT2 mutations on splicing.
Howell Viive M; Gill Anthony; Clarkson Adele; Nelson Anne E; Dunne Robert; Delbridge Leigh W; Robinson Bruce G; Teh Bin T; Gimm Oliver; Marsh Deborah J
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
Marsh Deborah J; Trahair Toby N; Martin Janet L; Chee Wey Yeeng; Walker Jan; Kirk Edwin P; Baxter Robert C; Marshall Glenn M
Rapamycin treatment for a child with germline PTEN mutation.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Deborah Marsh (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hahn Michael A; McDonnell Julie; Marsh Deborah J
The effect of disease-associated HRPT2 mutations on splicing.
The Journal of endocrinology 2009;201(3):387-96.
2009: Howell Viive M; Gill Anthony; Clarkson Adele; Nelson Anne E; Dunne Robert; Delbridge Leigh W; Robinson Bruce G; Teh Bin T; Gimm Oliver; Marsh Deborah J
Accuracy of combined protein gene product 9.5 and parafibromin markers for immunohistochemical diagnosis of parathyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2009;94(2):434-41.
2008: Marsh Deborah J; Trahair Toby N; Martin Janet L; Chee Wey Yeeng; Walker Jan; Kirk Edwin P; Baxter Robert C; Marshall Glenn M
Rapamycin treatment for a child with germline PTEN mutation.
Nature clinical practice. Oncology 2008;5(6):357-61.
2007: Hahn Michael A; Marsh Deborah J
Nucleolar localization of parafibromin is mediated by three nucleolar localization signals.
FEBS letters 2007;581(26):5070-4.
2006: Howell Viive M; Cardinal John W; Richardson Anne-Louise; Gimm Oliver; Robinson Bruce G; Marsh Deborah J
Rapid mutation screening for HRPT2 and MEN1 mutations associated with familial and sporadic primary hyperparathyroidism.
The Journal of molecular diagnostics : JMD 2006;8(5):559-66.
2006: Gill Anthony J; Clarkson Adele; Gimm Oliver; Keil Juliane; Dralle Henning; Howell Viive M; Marsh Deborah J
Loss of nuclear expression of parafibromin distinguishes parathyroid carcinomas and hyperparathyroidism-jaw tumor (HPT-JT) syndrome-related adenomas from sporadic parathyroid adenomas and hyperplasias.
The American journal of surgical pathology 2006;30(9):1140-9.
2006: Benn Diana E; Richardson Anne Louise; Marsh Deborah J; Robinson Bruce G
Genetic testing in pheochromocytoma- and paraganglioma-associated syndromes.
Annals of the New York Academy of Sciences 2006;1073():104-11.
2006: Benn Diana E; Gimenez-Roqueplo Anne-Paule; Reilly Jennifer R; Bertherat Jérôme; Burgess John; Byth Karen; Croxson Michael; Dahia Patricia L M; Elston Marianne; Gimm Oliver; Henley David; Herman Philippe; Murday Victoria; Niccoli-Sire Patricia; Pasieka Janice L; Rohmer Vincent; Tucker Kathy; Jeunemaitre Xavier; Marsh Deborah J; Plouin Pierre-François; Robinson Bruce G
Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes.
The Journal of clinical endocrinology and metabolism 2006;91(3):827-36.
2006: Moscova Michelle; Marsh Deborah J; Baxter Robert C
Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.
Cancer research 2006;66(3):1376-83.
2006: Gimm O; Lorenz K; Nguyen Thanh P; Schneyer U; Bloching M; Howell V M; Marsh D J; Teh B T; Krause U; Dralle H
[Prophylactic parathyroidectomy for familial parathyroid carcinoma]
Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen 2006;77(1):15-24.
2005: Hahn Michael A; Marsh Deborah J
Identification of a functional bipartite nuclear localization signal in the tumor suppressor parafibromin.
Oncogene 2005;24(41):6241-8.
2005: Dahia Patricia L M; Ross Ken N; Wright Matthew E; Hayashida César Y; Santagata Sandro; Barontini Marta; Kung Andrew L; Sanso Gabriela; Powers James F; Tischler Arthur S; Hodin Richard; Heitritter Shannon; Moore Francis; Dluhy Robert; Sosa Julie Ann; Ocal I Tolgay; Benn Diana E; Marsh Deborah J; Robinson Bruce G; Schneider Katherine; Garber Judy; Arum Seth M; Korbonits Márta; Grossman Ashley; Pigny Pascal; Toledo Sérgio P A; Nosé Vania; Li Cheng; Stiles Charles D
A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas.
PLoS genetics 2005;1(1):72-80.
2004: Haven Carola J; Howell Viive M; Eilers Paul H C; Dunne Robert; Takahashi Masayuki; van Puijenbroek Marjo; Furge Kyle; Kievit Job; Tan Min-Han; Fleuren Gert Jan; Robinson Bruce G; Delbridge Leigh W; Philips Jeanette; Nelson Anne E; Krause Ulf; Dralle Henning; Hoang-Vu Cuong; Gimm Oliver; Morreau Hans; Marsh Deborah J; Teh Bin T
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype.
Cancer research 2004;64(20):7405-11.
2004: Howell Viive M; Zori Roberto T; Stalker Heather J; Williams Charles; Jesse Nathan; Nelson Anne E; Robinson Bruce G; Marsh Deborah J
A molecular diagnosis of hyperparathyroidism-jaw tumor syndrome in an adolescent with recurrent kidney stones.
The Journal of pediatrics 2004;145(4):567.
2004: Marsh Deborah J; Morreau Hans; Teh Bin T
HRPT2 and parathyroid cancer.
The lancet oncology 2004;5(2):78.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):224.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):223.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):222.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):222.
2004: Teh B T; Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H
Human gene mutations. Gene symbol: HRPT2. Disease: Hyperparathyroidism Jaw-tumor syndrome.
Human genetics 2004;114(2):221.
2003: Zhou Xiao-Ping; Marsh Deborah J; Morrison Carl D; Chaudhury Abhik R; Maxwell Marius; Reifenberger Guido; Eng Charis
Germline inactivation of PTEN and dysregulation of the phosphoinositol-3-kinase/Akt pathway cause human Lhermitte-Duclos disease in adults.
American journal of human genetics 2003;73(5):1191-8.
2003: Howell V M; Haven C J; Kahnoski K; Khoo S K; Petillo D; Chen J; Fleuren G J; Robinson B G; Delbridge L W; Philips J; Nelson A E; Krause U; Hammje K; Dralle H; Hoang-Vu C; Gimm O; Marsh D J; Morreau H; Teh B T
HRPT2 mutations are associated with malignancy in sporadic parathyroid tumours.
Journal of medical genetics 2003;40(9):657-63.
2003: Marsh Deborah J; Theodosopoulos George; Martin-Schulte Klaus; Richardson Anne-Louise; Philips Jeanette; Röher Hans-Dietrich; Delbridge Leigh; Robinson Bruce G
Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.
The Journal of clinical endocrinology and metabolism 2003;88(4):1866-72.
2003: Benn Diana E; Croxson Michael S; Tucker Kathy; Bambach Christopher P; Richardson Anne Louise; Delbridge Leigh; Pullan Peter T; Hammond Jeremy; Marsh Deborah J; Robinson Bruce G
Novel succinate dehydrogenase subunit B (SDHB) mutations in familial phaeochromocytomas and paragangliomas, but an absence of somatic SDHB mutations in sporadic phaeochromocytomas.
Oncogene 2003;22(9):1358-64.
2002: Dwight Trisha; Nelson Anne E; Theodosopoulos George; Richardson Anne Louise; Learoyd Diana L; Philips Jeanette; Delbridge Leigh; Zedenius Jan; Teh Bin T; Larsson Catharina; Marsh Deborah J; Robinson Bruce G
Independent genetic events associated with the development of multiple parathyroid tumors in patients with primary hyperparathyroidism.
The American journal of pathology 2002;161(4):1299-306.
2002: Andrew Scott D; Capes-Davis Amanda; Delhanty Patric J D; Marsh Deborah J; Mulligan Lois M; Robinson Bruce G
Transcriptional repression of the RET proto-oncogene by a mitogen activated protein kinase-dependent signalling pathway.
Gene 2002;298(1):9-19.
2002: Sidhu Stan; Marsh Deborah J; Theodosopoulos George; Philips Jeanette; Bambach Christopher P; Campbell Peter; Magarey Christopher J; Russell Colin F J; Schulte Klaus-Martin; Röher Hans-Dietrich; Delbridge Leigh; Robinson Bruce G
Comparative genomic hybridization analysis of adrenocortical tumors.
The Journal of clinical endocrinology and metabolism 2002;87(7):3467-74.
2002: Dwight T; Kytölä S; Teh B T; Theodosopoulos G; Richardson A L; Philips J; Twigg S; Delbridge L; Marsh D J; Nelson A E; Larsson C; Robinson B G
Genetic analysis of lithium-associated parathyroid tumors.
European journal of endocrinology / European Federation of Endocrine Societies 2002;146(5):619-27.
2001: Holm I A; Nelson A E; Robinson B G; Mason R S; Marsh D J; Cowell C T; Carpenter T O
Mutational analysis and genotype-phenotype correlation of the PHEX gene in X-linked hypophosphatemic rickets.
The Journal of clinical endocrinology and metabolism 2001;86(8):3889-99.
2001: Marsh D J; Theodosopoulos G; Howell V; Richardson A L; Benn D E; Proos A L; Eng C; Robinson B G
Rapid mutation scanning of genes associated with familial cancer syndromes using denaturing high-performance liquid chromatography.
Neoplasia (New York, N.Y.) 2001;3(3):236-44.
2001: Marsh D J; Stratakis C A
Hamartoma and lentiginosis syndromes: clinical and molecular aspects.
Frontiers of hormone research 2001;28():167-213.
2000: Benn D E; Dwight T; Richardson A L; Delbridge L; Bambach C P; Stowasser M; Gordon R D; Marsh D J; Robinson B G
Sporadic and familial pheochromocytomas are associated with loss of at least two discrete intervals on chromosome 1p.
Cancer research 2000;60(24):7048-51.
2000: Gimm O; Perren A; Weng L P; Marsh D J; Yeh J J; Ziebold U; Gil E; Hinze R; Delbridge L; Lees J A; Mutter G L; Robinson B G; Komminoth P; Dralle H; Eng C
Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors.
The American journal of pathology 2000;156(5):1693-700.
2000: Zhou X P; Marsh D J; Hampel H; Mulliken J B; Gimm O; Eng C
Germline and germline mosaic PTEN mutations associated with a Proteus-like syndrome of hemihypertrophy, lower limb asymmetry, arteriovenous malformations and lipomatosis.
Human molecular genetics 2000;9(5):765-8.
1999: Faisal Ahmed S; Marsh D J; Weremowicz S; Morton C C; Williams D M; Eng C
Balanced translocation of 10q and13q, including the PTEN gene, in a boy with a human chorionic gonadotropin-secreting tumor and the Bannayan-Riley-Ruvalcaba syndrome.
The Journal of clinical endocrinology and metabolism 1999;84(12):4665-70.
1999: Yeh J J; Marsh D J; Zedenius J; Dwight T; Delbridge L; Robinson B G; Eng C
Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways.
Genes, chromosomes & cancer 1999;26(4):322-8.
1999: Marsh D J; Kum J B; Lunetta K L; Bennett M J; Gorlin R J; Ahmed S F; Bodurtha J; Crowe C; Curtis M A; Dasouki M; Dunn T; Feit H; Geraghty M T; Graham J M; Hodgson S V; Hunter A; Korf B R; Manchester D; Miesfeldt S; Murday V A; Nathanson K L; Parisi M; Pober B; Romano C; Eng C
PTEN mutation spectrum and genotype-phenotype correlations in Bannayan-Riley-Ruvalcaba syndrome suggest a single entity with Cowden syndrome.
Human molecular genetics 1999;8(8):1461-72.
1999: Gimm O; Gössling A; Marsh D J; Dahia P L; Mulligan L M; von Deimling A; Eng C
Mutation and deletion analysis of GFR alpha-1, encoding the co-receptor for the GDNF/RET complex, in human brain tumours.
British journal of cancer 1999;80(3-4):383-6.
1999: Gimm O; Neuberg D S; Marsh D J; Dahia P L; Hoang-Vu C; Raue F; Hinze R; Dralle H; Eng C
Over-representation of a germline RET sequence variant in patients with sporadic medullary thyroid carcinoma and somatic RET codon 918 mutation.
Oncogene 1999;18(6):1369-73.
1999: Dahia P L; Aguiar R C; Alberta J; Kum J B; Caron S; Sill H; Marsh D J; Ritz J; Freedman A; Stiles C; Eng C
PTEN is inversely correlated with the cell survival factor Akt/PKB and is inactivated via multiple mechanismsin haematological malignancies.
Human molecular genetics 1999;8(2):185-93.
1999: Capes-Davis A; Andrew S D; Hyland V J; Twigg S; Learoyd D L; Dwight T; Marsh D J; Robinson B G
Glucocorticoids differentially inhibit expression of the RET proto-oncogene.
Gene expression 1999;8(5-6):311-26.
1998: Eng C; Marsh D J; Robinson B G; Chow C W; Patton M A; Southey M C; Venter D J; Ponder B A; Milla P J; Smith V V
Germline RET codon 918 mutation in apparently isolated intestinal ganglioneuromatosis.
The Journal of clinical endocrinology and metabolism 1998;83(12):4191-4.
1998: Marsh D J; Dahia P L; Caron S; Kum J B; Frayling I M; Tomlinson I P; Hughes K S; Eeles R A; Hodgson S V; Murday V A; Houlston R; Eng C
Germline PTEN mutations in Cowden syndrome-like families.
Journal of medical genetics 1998;35(11):881-5.
1998: Peaston A E; Camacho M L; Norris M D; Haber M; Marsh D J; Robinson B G; Hyland V J; Marshall G M
Absence of MEN2A- or 2B-type RET mutations in primary neuroblastoma tumour tissue.
Molecular and cellular probes 1998;12(4):239-42.
1998: FitzGerald M G; Marsh D J; Wahrer D; Bell D; Caron S; Shannon K E; Ishioka C; Isselbacher K J; Garber J E; Eng C; Haber D A
Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer.
Oncogene 1998;17(6):727-31.
1998: Dahia P L; FitzGerald M G; Zhang X; Marsh D J; Zheng Z; Pietsch T; von Deimling A; Haluska F G; Haber D A; Eng C
A highly conserved processed PTEN pseudogene is located on chromosome band 9p21.
Oncogene 1998;16(18):2403-6.
1998: Marsh D J; Coulon V; Lunetta K L; Rocca-Serra P; Dahia P L; Zheng Z; Liaw D; Caron S; Duboué B; Lin A Y; Richardson A L; Bonnetblanc J M; Bressieux J M; Cabarrot-Moreau A; Chompret A; Demange L; Eeles R A; Yahanda A M; Fearon E R; Fricker J P; Gorlin R J; Hodgson S V; Huson S; Lacombe D; Eng C
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation.
Human molecular genetics 1998;7(3):507-15.
1998: Marsh D J; Dahia P L; Coulon V; Zheng Z; Dorion-Bonnet F; Call K M; Little R; Lin A Y; Eeles R A; Goldstein A M; Hodgson S V; Richardson A L; Robinson B G; Weber H C; Longy M; Eng C
Allelic imbalance, including deletion of PTEN/MMACI, at the Cowden disease locus on 10q22-23, in hamartomas from patients with Cowden syndrome and germline PTEN mutation.
Genes, chromosomes & cancer 1998;21(1):61-9.
1998: Gordon C m; Majzoub J A; Marsh D J; Mulliken J B; Ponder B A; Robinson B G; Eng C
Four cases of mucosal neuroma syndrome: multiple endocrine neoplasm 2B or not 2B?
The Journal of clinical endocrinology and metabolism 1998;83(1):17-20.
1998: Marsh D J; Andrew S D; Learoyd D L; Pojer R; Eng C; Robinson B G
Deletion-insertion mutation encompassing RET codon 634 is associated with medullary thyroid carcinoma.
Human mutation 1998;Suppl 1():S3-4.
1997: Marsh D J; Roth S; Lunetta K L; Hemminki A; Dahia P L; Sistonen P; Zheng Z; Caron S; van Orsouw N J; Bodmer W F; Cottrell S E; Dunlop M G; Eccles D; Hodgson S V; Järvinen H; Kellokumpu I; Markie D; Neale K; Phillips R; Rozen P; Syngal S; Vijg J; Tomlinson I P; Aaltonen L A; Eng C
Exclusion of PTEN and 10q22-24 as the susceptibility locus for juvenile polyposis syndrome.
Cancer research 1997;57(22):5017-21.
1997: Gimm O; Marsh D J; Andrew S D; Frilling A; Dahia P L; Mulligan L M; Zajac J D; Robinson B G; Eng C
Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation.
The Journal of clinical endocrinology and metabolism 1997;82(11):3902-4.
1997: Dahia P L; Marsh D J; Zheng Z; Zedenius J; Komminoth P; Frisk T; Wallin G; Parsons R; Longy M; Larsson C; Eng C
Somatic deletions and mutations in the Cowden disease gene, PTEN, in sporadic thyroid tumors.
Cancer research 1997;57(21):4710-3.
1997: Learoyd D L; Marsh D J; Richardson A L; Twigg S M; Delbridge L; Robinson B G
Genetic testing for familial cancer. Consequences of RET proto-oncogene mutation analysis in multiple endocrine neoplasia, type 2.
Archives of surgery (Chicago, Ill. : 1960) 1997;132(9):1022-5.
1997: Marsh D J; Zheng Z; Arnold A; Andrew S D; Learoyd D; Frilling A; Komminoth P; Neumann H P; Ponder B A; Rollins B J; Shapiro G I; Robinson B G; Mulligan L M; Eng C
Mutation analysis of glial cell line-derived neurotrophic factor, a ligand for an RET/coreceptor complex, in multiple endocrine neoplasia type 2 and sporadic neuroendocrine tumors.
The Journal of clinical endocrinology and metabolism 1997;82(9):3025-8.
1997: Marsh D J; Dahia P L; Zheng Z; Liaw D; Parsons R; Gorlin R J; Eng C
Germline mutations in PTEN are present in Bannayan-Zonana syndrome.
Nature genetics 1997;16(4):333-4.
1997: Liaw D; Marsh D J; Li J; Dahia P L; Wang S I; Zheng Z; Bose S; Call K M; Tsou H C; Peacocke M; Eng C; Parsons R
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome.
Nature genetics 1997;16(1):64-7.
1997: Marsh D J; Zheng Z; Zedenius J; Kremer H; Padberg G W; Larsson C; Longy M; Eng C
Differential loss of heterozygosity in the region of the Cowden locus within 10q22-23 in follicular thyroid adenomas and carcinomas.
Cancer research 1997;57(3):500-3.
1996: Eng C; Clayton D; Schuffenecker I; Lenoir G; Cote G; Gagel R F; van Amstel H K; Lips C J; Nishisho I; Takai S I; Marsh D J; Robinson B G; Frank-Raue K; Raue F; Xue F; Noll W W; Romei C; Pacini F; Fink M; Niederle B; Zedenius J; Nordenskjöld M; Komminoth P; Hendy G N; Mulligan L M
The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.
JAMA : the journal of the American Medical Association 1996;276(19):1575-9.
1996: Marsh D J; Learoyd D L; Andrew S D; Krishnan L; Pojer R; Richardson A L; Delbridge L; Eng C; Robinson B G
Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma.
Clinical endocrinology 1996;44(3):249-57.
1996: Marsh D J; Andrew S D; Eng C; Learoyd D L; Capes A G; Pojer R; Richardson A L; Houghton C; Mulligan L M; Ponder B A; Robinson B G
Germline and somatic mutations in an oncogene: RET mutations in inherited medullary thyroid carcinoma.
Cancer research 1996;56(6):1241-3.
1996: Marsh D J; McDowall D; Hyland V J; Andrew S D; Schnitzler M; Gaskin E L; Nevell D F; Diamond T; Delbridge L; Clifton-Bligh P; Robinson B G
The identification of false positive responses to the pentagastrin stimulation test in RET mutation negative members of MEN 2A families.
Clinical endocrinology 1996;44(2):213-20.
1995: Schnitzler M; Dwight T; Marsh D J; Gaskin E L; Robinson B G
Quantitation of APC mRNA in human tissues.
Biochemical and biophysical research communications 1995;217(2):385-92.
1995: Marsh D J; Learoyd D L; Robinson B G
Medullary thyroid carcinoma: recent advances and management update.
Thyroid : official journal of the American Thyroid Association 1995;5(5):407-24.
1995: Mulligan L M; Marsh D J; Robinson B G; Schuffenecker I; Zedenius J; Lips C J; Gagel R F; Takai S I; Noll W W; Fink M
Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.
Journal of internal medicine 1995;238(4):343-6.
1994: Mulligan L M; Eng C; Attié T; Lyonnet S; Marsh D J; Hyland V J; Robinson B G; Frilling A; Verellen-Dumoulin C; Safar A
Diverse phenotypes associated with exon 10 mutations of the RET proto-oncogene.
Human molecular genetics 1994;3(12):2163-7.
1994: Marsh D J; Robinson B G; Andrew S; Richardson A L; Pojer R; Schnitzler M; Mulligan L M; Hyland V J
A rapid screening method for the detection of mutations in the RET proto-oncogene in multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma families.
Genomics 1994;23(2):477-9.
1992: Ward J L; Hyland V J; Andrew D S; Marsh D J; Robinson B G
Medullary thyroid carcinoma: Australian experience with genetic testing.
Henry Ford Hospital medical journal 1992;40(3-4):220-3.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Deborah Marsh

Research Profile (preview)

Chemicals & Drugs

Physiology

Disorders

Procedures

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Deborah Marsh (preview)

All Publications